-
Reliance Industr
1,411.85 1,608.95(%) -
Mazagon Dock
3,149.70 3,149.70(%) -
Bajaj Finance
8,560.00 6,376.55(%) -
Garden Reach Sh.
1,855.00 890.05(%) -
Cochin Shipyard
1,575.50 1,169.00(%) -
Tata Motors
641.10 542.55(%) -
Hind.Aeronautics
4,466.00 3,045.95(%) -
Paras Defence
1,469.00 1,592.75(%) -
Torrent Pharma.
3,300.00 2,513.05(%) -
Sonata Software
446.50 762.00(%) -
Data Pattern
2,450.00 1,350.50(%) -
IndusInd Bank
843.10 1,550.00(%) -
Samvardh. Mothe.
131.75 107.30(%) -
Bharat Electron
312.50 221.00(%) -
Trent
5,130.00 4,197.50(%) -
Varun Beverages
507.45 419.40(%) -
ICICI Bank
1,415.10 1,051.50(%) -
Vedanta
423.20 527.00(%) -
Hitachi Energy
14,879.00 16,534.50(%) -
Tech Mahindra
1,510.60 1,807.40(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Dr Lal Pathlabs Ltd Healthcare
- Indian Private
- BSE Code : 41261.0
- ISIN : INE600L01024
-
Today’s Low
2,740.50 -
Today’s High
2,849.90

-
Open
2,778.00 -
Perv Close
2,777.80 -
52W Low
2,201.20 -
52W High
3,653.95
Key Indicators
-
P/E(TTM)
46.50
-
Mar.Cap (₹Cr.)
23,147.39
-
Div & Yield %
0.87
-
Book Value(₹)
255.31
-
Debt-Equity Ratio
-0.31
-
AGM Date
30-Apr-2025
-
EPS
59.49
-
P/E Ratio
46.50
Financials Ratios
-
Debt-Equity Ratio
0.19
-
Mar.Cap (₹Cr.)
23,147.39
-
RONW (%)
20.61
-
ROCE (%)
25.58
Score Board
-
Equity (₹ in Cr.)
83.59
-
BV (₹)
255.30
-
Sales( ₹ in Cr.)
2,351.60
-
NP (in Cr.)
497.30
-
NP Var(%)
29.0
-
Div%
240.0
-
CPS (₹)
75.50
-
EPS (₹)
59.50
-
Traded Value (₹ in Lakhs)
23,125.65
-
52 Week High
3,653.95
-
52 Week Low
2,201.20
-
Price BSE
2767.0
-
Price NSE
2,769.00
-
Market Capital( in Cr.)
23,125.65
-
P/C Ratio
36.60
-
P/E Ratio
46.50
-
Price Vs.BV
59.50
-
25-Apr-2025( 03:23)
Corporate News - Board... - Dr. Lal PathLabs announced tha...
-
25-Apr-2025( 03:23)
Corporate News - Dr. L... - Dr. Lal PathLabs announced tha...
-
25-Apr-2025( 02:47)
Results - Announcements - Dr La... - Net profit of Dr Lal Pathlabs...
-
19-Apr-2025( 10:39)
Corporate News - Dr. L... - Dr. Lal PathLabs will hold a m...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar | 2019 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 1,966.76 | 1,769.03 | 1,878.79 | 1,490.56 | 1,273.60 | 1,164.90 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 1,966.76 | 1,769.03 | 1,878.79 | 1,490.56 | 1,273.60 | 1,164.90 |
Other Income | 60.11 | 46.60 | 53.10 | 51.27 | 57.61 | 46.49 |
Stock Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Income | 2,026.87 | 1,815.63 | 1,931.89 | 1,541.83 | 1,331.21 | 1,211.39 |
EXPENDITURE : | ||||||
Raw Materials | 390.76 | 389.64 | 447.65 | 373.90 | 286.87 | 254.96 |
Power and Fuel Cost | 21.54 | 21.31 | 19.66 | 17.18 | 15.65 | 14.65 |
Employee Cost | 363.59 | 315.50 | 321.44 | 257.44 | 232.07 | 201.86 |
Other Manufacturing Expenses | 376.33 | 344.15 | 336.38 | 243.96 | 212.40 | 187.49 |
Selling and Administration Expenses | 209.38 | 196.57 | 196.04 | 152.52 | 161.60 | 185.67 |
Miscellaneous Expenses | 45.93 | 41.17 | 45.16 | 38.18 | 37.20 | 37.47 |
Employee Benefit Expenses | 363.59 | 315.50 | 321.44 | 257.44 | 232.07 | 201.86 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 1,407.52 | 1,308.33 | 1,366.32 | 1,083.18 | 945.79 | 882.10 |
Operating Profit | 619.35 | 507.30 | 565.57 | 458.65 | 385.42 | 329.29 |
Interest | 26.84 | 34.38 | 28.63 | 14.83 | 14.66 | 0.74 |
Gross Profit | 592.51 | 472.92 | 536.94 | 443.82 | 370.76 | 328.55 |
Depreciation | 76.54 | 82.09 | 75.94 | 69.78 | 68.01 | 36.18 |
Profit Before Tax | 515.97 | 390.83 | 461.00 | 374.04 | 302.75 | 292.37 |
Current Tax | 137.58 | 101.44 | 118.42 | 98.43 | 80.25 | 100.54 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | -5.98 | -2.97 | -2.68 | -4.49 | -0.67 | -3.62 |
Reported Net Profit | 384.37 | 292.36 | 345.25 | 280.11 | 223.18 | 195.44 |
Extraordinary Items | 0.24 | 1.11 | 0.20 | -0.13 | 0.11 | 0.05 |
Adjusted Net Profit | 384.13 | 291.25 | 345.05 | 280.24 | 223.07 | 195.39 |
Adjustment below Net Profit | -0.27 | 1.94 | -1.32 | -0.71 | -6.72 | -6.76 |
P & L Balance brought forward | 1,378.66 | 1,183.79 | 955.56 | 773.56 | 704.92 | 565.80 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 199.48 | 99.43 | 115.71 | 99.11 | 147.82 | 49.56 |
P & L Balance carried down | 1,563.28 | 1,378.66 | 1,183.79 | 953.84 | 773.56 | 704.92 |
Dividend | 149.65 | 49.72 | 115.71 | 99.11 | 98.93 | 20.59 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 180.00 | 60.00 | 120.00 | 200.00 | 120.00 | 60.00 |
Dividend Per Share(Rs) | 18.00 | 6.00 | 12.00 | 20.00 | 12.00 | 6.00 |
Earnings Per Share-Unit Curr | 46.04 | 35.07 | 41.42 | 33.61 | 26.78 | 23.45 |
Earnings Per Share(Adj)-Unit Curr | 46.04 | 35.07 | 41.42 | 33.61 | 26.78 | 23.45 |
Book Value | 227.56 | 202.70 | 176.63 | 146.03 | 124.83 | 115.02 |
Book Value(Adj)-Unit Curr | 227.56 | 202.70 | 176.63 | 146.03 | 124.83 | 115.02 |